Similar drugsTo uncover
Dosage form: & nbspinjection
Composition:

Composition per 1 ampoule:

Bioactive extract from shallow sea fish - 1.0 ml includes:

Active substance: Extract concentrated from shallow sea fish - 0.1 g / ml

Excipients: phenol - up to 0,005 g / ml; water for injection up to 1.0 ml.
Description:Colorless or from light yellow to light brownish-yellow liquid.
Pharmacotherapeutic group:Reparation of tissue stimulator of natural origin
ATX: & nbsp
  • Other drugs for the treatment of diseases of the musculoskeletal system
  • Pharmacodynamics:

    AMBENE® A bio-chondroprotector, the active component of which is a bioactive extract from small marine fish. The extract contains mucopolysaccharides (chondroitin sulfate), amino acids, peptides, sodium, potassium, calcium, magnesium, iron, copper and zinc ions.

    AMBENE® Bio prevents the destruction of macromolecular structures of normal tissues, stimulates the recovery processes in the interstitial tissue and tissues of the articular cartilage, which explains its analgesic effect.

    Anti-inflammatory action and tissue regeneration are based on inhibition of hyaluronidase activity and normalization of biosynthesis of hyaluronic acid. Both of these effects are synergistic and cause the activation of restorative processes in the tissues (in particular, the restoration of the structure of the cartilage).

    Indications:

    AMBENE® Bio is used in adults with primary and secondary osteoarthrosis of different localization (coxarthrosis, gonarthrosis, arthrosis of small joints), osteochondrosis and spondylosis.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Pregnancy and lactation.

    Childhood.

    Carefully:

    It is not recommended to prescribe the drug in adolescence because of the lack of scientific clinical data in this category of patients.

    Pregnancy and lactation:Ambene® Bio is contraindicated in pregnancy. If you need to use the drug during lactation, breastfeeding should be discontinued.
    Dosing and Administration:

    With polyostoarthrosis and osteochondrosis, the drug is administered intramuscularly 1 ml per day. The course of treatment is 20 injections (1 injection per day for 20 days).

    With the primary lesion of large joints, the drug is administered intra-articularly 1-2 ml in each joint at intervals of 3-4 days. A total of 5-6 injections per course in each joint.

    A combination of intraarticular and intramuscular injection is possible.

    The course of treatment should be repeated 6 months after the doctor's consultation.
    Side effects:

    The incidence of adverse reactions listed below was determined according to the following gradation: very often (> 1/10), often (> 1/100, ≤1 / 10), infrequently (> 1/1000, <1/100), rarely (> 1/10000, ≤1 / 1000), very rarely (≤1 / 10000).

    Allergic reactions: rarely - itching; very rarely - anaphylactic reactions. Local: rarely - redness of the skin and burning sensation at the injection site.

    Other: short-term myalgia. In some cases, with intra-articular injections, there may be a transient increase in the pain syndrome.

    Overdose:

    In case of an overdose in predisposed patients, allergic reactions (sometimes severe) may occur.

    Interaction:

    So far, not identified.

    Special instructions:

    In the case of individual intolerance to seafood (sea fish), the risk of allergic reactions increases.

    Effect on the ability to drive transp. cf. and fur:

    Data on the adverse effects of the drug on the ability to drive vehicles and mechanisms are not available.

    Form release / dosage:

    Injection.

    Packaging:

    By 1.0 ml in ampoules of light-protective (SNS-1) or brown (NB) imported glass.

    5 ampoules are placed in a contour mesh package made of a polyvinyl chloride film.

    2 contour mesh packs together with instructions for use are placed in a pack of cardboard. In the pack put knife ampoule or scarifier.

    When using ampoules with a kink ring or notch and a point, the ampoule knife or scarifier is not inserted.

    Storage conditions:

    In the dark place at a temperature of 15-25 ° C.

    Keep out of the reach of children.

    Shelf life:2 years. Do not use after the expiration date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LP-004183
    Date of registration:15.03.2017
    Expiration Date:15.03.2022
    The owner of the registration certificate:En.S. Pharmaceuticals, LLCEn.S. Pharmaceuticals, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp04.04.2017
    Illustrated instructions
      Instructions
      Up